The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.

about

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials.

P2860

Q55380047-1FE4007E-D3A1-4DFD-B75F-B895926F9531

P2860

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.

Item

http://www.wikidata.org/entity/Q42284707

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The role of endothelial nitric ...... n a mouse model of restenosis.

@en

The role of endothelial nitric ...... n a mouse model of restenosis.

@nl

type

Item

label

The role of endothelial nitric ...... n a mouse model of restenosis.

@en

The role of endothelial nitric ...... n a mouse model of restenosis.

@nl

prefLabel

The role of endothelial nitric ...... n a mouse model of restenosis.

@en

The role of endothelial nitric ...... n a mouse model of restenosis.

@nl

P1476

The role of endothelial nitric ...... in a mouse model of restenosis

@en

P2093

Hideki Kushima

http://www.w3.org/2001/XMLSchema#string

Kyoko Kohashi

http://www.w3.org/2001/XMLSchema#string

Masakazu Koshibu

http://www.w3.org/2001/XMLSchema#string

Michishige Terasaki

http://www.w3.org/2001/XMLSchema#string

Munenori Hiromura

http://www.w3.org/2001/XMLSchema#string

Tomoyasu Fukui

http://www.w3.org/2001/XMLSchema#string

Tsutomu Hirano

http://www.w3.org/2001/XMLSchema#string

P2860

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters

Nitric oxide synthases: regulation and function

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase

Mechanisms by which diabetes increases cardiovascular disease.

FFA-induced hepatic insulin resistance in vivo is mediated by PKCδ, NADPH oxidase, and oxidative stress.

A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion

ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting.

Liraglutide attenuates high glucose-induced abnormal cell migration, proliferation, and apoptosis of vascular smooth muscle cells by activating the GLP-1 receptor, and inhibiting ERK1/2 and PI3K/Akt signaling pathways.

P2888

s12933-017-0603-x

P304

122

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-017-0603-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yusaku Mori

P577

2017-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092053651

http://www.w3.org/2001/XMLSchema#string

P698

28969637

http://www.w3.org/2001/XMLSchema#string

P921

endothelium

P932

5625638

http://www.w3.org/2001/XMLSchema#string

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.

about

P2860

P2860

The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P921

P932